Intravenous Sedation Versus General Anesthesia in Patients Undergoing Minor Gynecologic Surgery
Status: | Recruiting |
---|---|
Conditions: | Chronic Pain, Hospital |
Therapuetic Areas: | Musculoskeletal, Other |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 10/14/2017 |
Start Date: | June 2012 |
End Date: | December 2017 |
Contact: | Shireen Ahmad, M.D. |
Email: | sah704@northwewstern.edu |
Phone: | 312-472-3585 |
A Comparison of the Effect of Intravenous Sedation Versus General Anesthesia in Patients Undergoing Minor Gynecologic Surgery
The use of deep sedation may improve the quality of recovery of patients undergoing minor
gynecologic procedures. These patients may also have shorter hospital stays and potentially
lower healthcare costs. Additionally, the use of deep sedation for second trimester pregnancy
termination may be associated with less bleeding, a smaller decrease in perioperative
hemoglobin and better quality of recovery.
gynecologic procedures. These patients may also have shorter hospital stays and potentially
lower healthcare costs. Additionally, the use of deep sedation for second trimester pregnancy
termination may be associated with less bleeding, a smaller decrease in perioperative
hemoglobin and better quality of recovery.
Inclusion Criteria:
- Female patients undergoing second trimester abortions:
- Pregnancy: 12-24 weeks gestational size
- ASA PS I and II
- No history of diabetes mellitus, GERD or sleep apnea
- Age: > 18 years of age
- Fluent in English
Exclusion Criteria:
- ASA PSIII, Emergency surgery
- Pregnancy: > 24 weeks gestational size
- Age: < 18 years of age
- Diabetes mellitus
- Gastroesophageal reflux disease
- Hiatal hernia
- Obstructive sleep apnea
- Coagulopathy
- Chronic pain syndromes
- Chronic opioid dependency
- Alcohol or illicit drug abuse
- BMI: > 35Kg/m2
- Allergy to study protocol drugs
Drop out criteria:
- Subjects withdrawal of consent.
- Subjects who experience massive bleeding intraoperatively, will be excluded from the
final data analysis
We found this trial at
1
site
Chicago, Illinois 60611
Principal Investigator: Shireen Ahmad, M.D.
Phone: 312-472-3585
Click here to add this to my saved trials